Literature DB >> 25973101

MC4R expression in pedunculopontine nucleus involved in the modulation of midbrain dopamine system.

Yan Hao1, Xue-Bi Tian2, Tao-Tao Liu2, Cheng Liu2, Hong-Bing Xiang2, Jian-Guo Zhang3.   

Abstract

BACKGROUND AND
OBJECTIVE: Separate studies have implicated the pedunculopontine tegmental nucleus (PPTg) in processing aversive stimuli to dopamine systems, and melanocortin-4 receptor (MC4R) are broadly expressed by the neurons in the PPTg, but the exact neurosubstrate underlying the regulation of dopamine systems by the central melanocortin pathway is poorly understood.
METHODS: In this study, the PPTg of 6 adult mice expressing green fluorescent protein (GFP) under the control of the MC4R promoter was detected by fluorescence immunohistochemistry.
RESULTS: A large number of GFP-positive neurons in the dissipated parts of PPTg (dpPPTg) were found, and approximately 50% of MC4R-GFP- positive neurons in the dpPPTg coexpressed tyrosine hydroxylase, a marker of dopamine neurons, indicating that they were dopaminergic.
CONCLUSIONS: Our findings support the hypothesis that MC4R signaling in the dpPPTg may involve in the modulation of midbrain dopamine systems.

Entities:  

Keywords:  Melanocortin-4 receptor; dopamine; the pedunculopontine tegmental nucleus

Mesh:

Substances:

Year:  2015        PMID: 25973101      PMCID: PMC4396322     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  35 in total

1.  The MC4 receptor mediates alpha-MSH induced release of nucleus accumbens dopamine.

Authors:  J Lindblom; B Opmane; F Mutulis; I Mutule; R Petrovska; V Klusa; L Bergström; J E Wikberg
Journal:  Neuroreport       Date:  2001-07-20       Impact factor: 1.837

2.  Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat.

Authors:  Hui-Ling Wang; Marisela Morales
Journal:  Eur J Neurosci       Date:  2009-01       Impact factor: 3.386

3.  Where are the somatosensory evoked potentials recorded from DBS leads implanted in the human pedunculopontine tegmental nucleus generated?

Authors:  Angelo Insola; Luca Padua; Eugenio Scarnati; Massimiliano Valeriani
Journal:  Mov Disord       Date:  2011-04-29       Impact factor: 10.338

Review 4.  Synaptic changes induced by melanocortin signalling.

Authors:  Vanni Caruso; Malin C Lagerström; Pawel K Olszewski; Robert Fredriksson; Helgi B Schiöth
Journal:  Nat Rev Neurosci       Date:  2014-02       Impact factor: 34.870

5.  Deep brain stimulation for locomotor recovery following spinal cord injury.

Authors:  Mark Richardson
Journal:  Neurosurgery       Date:  2014-02       Impact factor: 4.654

6.  The mesencephalic locomotor region. I. Activation of a medullary projection site.

Authors:  E Garcia-Rill; R D Skinner
Journal:  Brain Res       Date:  1987-05-12       Impact factor: 3.252

7.  Gender-specific roles for the melanocortin-3 receptor in the regulation of the mesolimbic dopamine system in mice.

Authors:  Rachel N Lippert; Kate L J Ellacott; Roger D Cone
Journal:  Endocrinology       Date:  2014-02-26       Impact factor: 4.736

8.  Development of a high throughput screen for allosteric modulators of melanocortin-4 receptor signaling using a real time cAMP assay.

Authors:  Jacques Pantel; Savannah Y Williams; Dehui Mi; Julien Sebag; Jackie D Corbin; C David Weaver; Roger D Cone
Journal:  Eur J Pharmacol       Date:  2011-02-04       Impact factor: 4.432

9.  Stimulation of the pedunculopontine tegmental nucleus may affect renal function by melanocortinergic signaling.

Authors:  Cheng Liu; Da-Wei Ye; Xue-Hai Guan; Rong-Chun Li; Hong-Bing Xiang; Wen-Zhen Zhu
Journal:  Med Hypotheses       Date:  2013-05-01       Impact factor: 1.538

10.  Motor cortex-periaqueductal gray-spinal cord neuronal circuitry may involve in modulation of nociception: a virally mediated transsynaptic tracing study in spinally transected transgenic mouse model.

Authors:  Da-Wei Ye; Cheng Liu; Tao-Tao Liu; Xue-Bi Tian; Hong-Bing Xiang
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

View more
  7 in total

1.  Melanocortin-4 receptor expression in the cuneiform nucleus is involved in modulation of opioidergic signaling.

Authors:  Yong-Tang Song; Tao-Tao Liu; Li Feng; Tao Zhang; Hong-Bing Xiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

Review 2.  Alteration of circadian rhythm during epileptogenesis: implications for the suprachiasmatic nucleus circuits.

Authors:  Yan Xiang; Zhi-Xiao Li; Ding-Yu Zhang; Zhi-Gang He; Ji Hu; Hong-Bing Xiang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-06-15

Review 3.  Consciousness loss during epileptogenesis: implication for VLPO-PnO circuits.

Authors:  Maohui Feng; Zhigang He; Baowen Liu; Zhixiao Li; Guorong Tao; Duozhi Wu; Hongbing Xiang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-02-15

4.  Neuroanatomical circuitry between kidney and rostral elements of brain: a virally mediated transsynaptic tracing study in mice.

Authors:  Ye-Ting Zhou; Zhi-Gang He; Tao-Tao Liu; Mao-Hui Feng; Ding-Yu Zhang; Hong-Bing Xiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-02-22

5.  Neuroanatomical autonomic substrates of brainstem-gut circuitry identified using transsynaptic tract-tracing with pseudorabies virus recombinants.

Authors:  Zhi-Gang He; Quan Wang; Run-Shan Xie; Yong-Sheng Li; Qing-Xiong Hong; Hong-Bing Xiang
Journal:  Am J Clin Exp Immunol       Date:  2018-04-05

Review 6.  The melanocortin system as a potential target for treating alcohol use disorders: A review of pre-clinical data.

Authors:  José Manuel Lerma-Cabrera; Francisca Carvajal; James C Garbutt; Montserrat Navarro; Todd E Thiele
Journal:  Brain Res       Date:  2019-12-28       Impact factor: 3.252

7.  Delineation of the central melanocortin circuitry controlling the kidneys by a virally mediated transsynaptic tracing study in transgenic mouse model.

Authors:  Tao Tao Liu; Bao Wen Liu; Zhi Gang He; Li Feng; San Guang Liu; Hong Bing Xiang
Journal:  Oncotarget       Date:  2016-10-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.